NewsWhore
12-17-2010, 09:30 PM
LONDON: Astrazeneca’s new heart medicine Brilinta failed to win approval from US regulators, delaying a vital new product designed to rival Plavix , the world's second-biggest selling drug. The drug...
More... (http://story.argentinastar.com/index.php/ct/9/cid/d9ed072d737073b4/id/41354667/)
More... (http://story.argentinastar.com/index.php/ct/9/cid/d9ed072d737073b4/id/41354667/)